Sulfonyl-phenyl-ureido benzamidines

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

The high throughput in silico screening of a virtual library into the structure of the P. falciparum lactate dehydrogenase (LDH) with the 4SCan technology yielded a series of biphenyl urea compounds. These were chemically optimized to a new structural class of potent antimalarial agents. The compounds did not inhibit plasmodium LDH enough to fully explain their potency. Therefore we conclude that an unknown mode of action may be the cause of the antimalarial activity.

Knowledge Graph

Similar Paper

Sulfonyl-phenyl-ureido benzamidines
Bioorganic & Medicinal Chemistry Letters 2004.0
Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment
Bioorganic & Medicinal Chemistry Letters 2013.0
Identification of Novel Phenyl Butenonyl C-Glycosides with Ureidyl and Sulfonamidyl Moieties as Antimalarial Agents
ACS Medicinal Chemistry Letters 2014.0
Synthesis and evaluation of sulfonylurea derivatives as novel antimalarials
European Journal of Medicinal Chemistry 2007.0
Synthesis and structure–activity relationship of disubstituted benzamides as a novel class of antimalarial agents
Bioorganic & Medicinal Chemistry Letters 2012.0
Molecular modeling studies, synthesis and biological evaluation of derivatives of N-phenylbenzamide as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors
Medicinal Chemistry Research 2011.0
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies PotentPlasmodium falciparumDihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Journal of Medicinal Chemistry 2011.0
Discovery of highly selective 7-chloroquinoline-thiohydantoins with potent antimalarial activity
European Journal of Medicinal Chemistry 2014.0
Lead selection of antiparasitic compounds from a focused library of benzenesulfonyl derivatives of heterocycles
Bioorganic & Medicinal Chemistry Letters 2017.0
Docking and Database Screening Reveal New Classes ofPlasmodiumfalciparumDihydrofolate Reductase Inhibitors
Journal of Medicinal Chemistry 2003.0